Reply to Kamp : Novel Insight into Pulmonary Fibrosis and Long Covid.
作者信息
Hatabu Hiroto, Kaye Kenneth M, Christiani David C
机构信息
Department of Radiology, Center for Pulmonary Functional Imaging, and.
Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
出版信息
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1108. doi: 10.1164/rccm.202301-0054LE.
Abstract
摘要
相似文献
1
Reply to Kamp : Novel Insight into Pulmonary Fibrosis and Long Covid.对坎普的回复：对肺纤维化和长期新冠的全新见解。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1108. doi: 10.1164/rccm.202301-0054LE.
2
αβ Integrin Positron Emission Tomography of Lung Fibrosis in Idiopathic Pulmonary Fibrosis and Long COVID-19.特发性肺纤维化和长新冠中肺纤维化的αβ整合素正电子发射断层扫描
Am J Respir Crit Care Med. 2023 Jun 15;207(12):1633-1635. doi: 10.1164/rccm.202206-1107IM.
3
Novel Insight into Pulmonary Fibrosis and Long COVID.对肺纤维化和长期新冠的新见解。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1105-1107. doi: 10.1164/rccm.202212-2314LE.
4
Early experience of nintedanib in COVID-19 ARDS-related pulmonary fibrosis: a case series.尼达尼布治疗 COVID-19 相关急性呼吸窘迫综合征肺纤维化的早期经验：一项病例系列研究。
Adv Respir Med. 2021;89(6):589-596. doi: 10.5603/ARM.a2021.0113.
5
Severe progression of idiopathic pulmonary fibrosis post-COVID-19 infection.新冠病毒感染后特发性肺纤维化的严重进展。
BMJ Case Rep. 2021 Oct 19;14(10):e244472. doi: 10.1136/bcr-2021-244472.
6
Radiological findings based comparison of functional status in patients who have post-covid lung injury or idiopathic pulmonary fibrosis.基于影像学发现的比较：新冠后肺损伤或特发性肺纤维化患者的功能状态。
BMC Pulm Med. 2023 Jun 30;23(1):234. doi: 10.1186/s12890-023-02527-z.
7
Pulmonary fibrosis in a dog as a sequela of infection with Severe Acute Respiratory Syndrome Coronavirus 2? A case report.犬感染严重急性呼吸综合征冠状病毒 2 后的肺纤维化？一例报告。
BMC Vet Res. 2022 Mar 22;18(1):111. doi: 10.1186/s12917-022-03191-x.
8
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.特发性肺纤维化急性加重患者的新冠病毒疫苗接种情况
Am J Respir Crit Care Med. 2022 Jul 15;206(2):219-221. doi: 10.1164/rccm.202112-2765LE.
9
Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.对拉伊乔特等人的回复：尼达尼布与吡非尼酮联合治疗特发性肺纤维化
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105-1106. doi: 10.1164/rccm.201806-1116LE.
10
Post covid 19 pulmonary fibrosis. Is it real threat?新冠后肺纤维化。这是真实存在的威胁吗？
Indian J Tuberc. 2021 Jul;68(3):330-333. doi: 10.1016/j.ijtb.2020.11.003. Epub 2020 Nov 10.
引用本文的文献
1
Clinical, Imaging, and Histopathological Features of Pulmonary Sequelae after Mild COVID-19.轻度新型冠状病毒肺炎后肺部后遗症的临床、影像学和组织病理学特征
Am J Respir Crit Care Med. 2023 Sep 1;208(5):618-621. doi: 10.1164/rccm.202302-0285LE.
本文引用的文献
1
Viral Infection, Pulmonary Fibrosis, and Long COVID.病毒感染、肺纤维化与新冠长期症状
Am J Respir Crit Care Med. 2023 Mar 15;207(6):647-649. doi: 10.1164/rccm.202211-2121ED.
2
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.新冠肺炎住院后肺部残留异常：英国 COVID-19 后研究的临时分析。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):693-703. doi: 10.1164/rccm.202203-0564OC.
3
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection.SARS-CoV-2 感染后持续性肺部疾病患者的临床、影像学和病理学表现。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02411-2021. Print 2022 Oct.
4
Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19.COVID-19 中肺纤维化的时相关联分子机制。
Int J Mol Sci. 2022 Jan 29;23(3):1583. doi: 10.3390/ijms23031583.
5
Spectrum of Fibrotic Lung Diseases.纤维化性肺疾病谱
N Engl J Med. 2020 Sep 3;383(10):958-968. doi: 10.1056/NEJMra2005230.
6
Idiopathic Pulmonary Fibrosis.特发性肺纤维化
N Engl J Med. 2018 May 10;378(19):1811-1823. doi: 10.1056/NEJMra1705751.
Zotero 插件